Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.834 USD | -5.12% | +1.27% | -27.93% |
Mar. 15 | Cytosorbents Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Earnings Flash (CTSO) CYTOSORBENTS Reports Q4 Revenue $8.7M, vs. Street Est of $9.8M | MT |
Financials (USD)
Sales 2024 * | 40.31M | Sales 2025 * | 47.76M | Capitalization | 47.74M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -9M | EV / Sales 2024 * | 1.18 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1 x |
P/E ratio 2024 * |
-2.44
x | P/E ratio 2025 * |
-4.32
x | Employees | 186 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.62% |
Latest transcript on Cytosorbents Corporation
1 day | -5.12% | ||
1 week | +1.27% | ||
Current month | -15.79% | ||
1 month | -11.83% | ||
3 months | -10.11% | ||
6 months | -58.76% | ||
Current year | -27.93% |
Managers | Title | Age | Since |
---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Vincent Capponi
PSD | President | 66 | 02-04-24 |
Kathleen Bloch
DFI | Director of Finance/CFO | 69 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bator
CHM | Chairman | 60 | 15-07-13 |
Phillip Chan
CEO | Chief Executive Officer | 53 | 08-07-23 |
Edward Jones
BRD | Director/Board Member | 75 | 07-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.20% | 12 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 0.8 | -8.99% | 135 613 |
24-04-23 | 0.879 | +8.52% | 108,104 |
24-04-22 | 0.81 | +1.00% | 97,907 |
24-04-19 | 0.802 | +0.12% | 46,299 |
24-04-18 | 0.801 | +1.39% | 101,761 |
Delayed Quote Nasdaq, April 24, 2024 at 02:13 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.93% | 47.74M | |
+8.25% | 219B | |
+8.00% | 187B | |
+10.72% | 134B | |
+26.68% | 101B | |
+0.30% | 62.27B | |
+16.07% | 52.82B | |
-1.63% | 47.49B | |
-1.42% | 40.79B | |
+11.98% | 39.35B |
- Stock Market
- Equities
- CTSO Stock